These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26029570)

  • 1. Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis.
    Onda N; Tanaka Y; Hino M; Gemma A
    Respir Med Case Rep; 2015; 14():19-23. PubMed ID: 26029570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis-an interim analysis of results from a prospective, single-center, randomized, parallel-group study.
    Tanaka Y; Hino M; Gemma A
    BMC Pulm Med; 2017 Dec; 17(1):200. PubMed ID: 29237441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of anti-aminoacyl tRNA synthetase (ARS) antibody-positive polymyositis (PM)/dermatomyositis (DM)-associated interstitial pneumonia (IP) successfully controlled with bosentan therapy.
    Naito T; Tanaka Y; Hino M; Gemma A
    Respir Med Case Rep; 2017; 21():62-65. PubMed ID: 28393009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].
    Liu Q; Zhang C; Li QQ; Zhu Y; Zhang D; Zhao WG; Gu H
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):23-28. PubMed ID: 29342993
    [No Abstract]   [Full Text] [Related]  

  • 6. Initial and programmed combination therapy with oral drugs for severe idiopathic pulmonary arterial hypertension.
    Maki H; Yao A; Inaba T; Shiga T; Hatano M; Kinugawa K; Yamashita T; Aizawa T; Nagai R
    Int Heart J; 2011; 52(5):323-6. PubMed ID: 22008445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax.
    Jacheć W; Tomasik A; Kurzyna M; Pietura R; Torbicki A; Głowacki J; Nowalany-Kozielska E; Wojciechowska C
    BMC Pulm Med; 2019 Apr; 19(1):80. PubMed ID: 30991994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis.
    Pouwels-Fry S; Pouwels S; Fournier C; Duchemin A; Tillie-Leblond I; Le Tourneau T; Wallaert B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):133-9. PubMed ID: 19382532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan.
    Schroll S; Arzt M; Sebah D; Nüchterlein M; Blumberg F; Pfeifer M
    Respir Physiol Neurobiol; 2010 Jan; 170(1):32-6. PubMed ID: 19931426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan.
    Prakash A; Perry CM
    Am J Cardiovasc Drugs; 2002; 2(5):335-43; discussion 343. PubMed ID: 14727963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].
    Liu XQ; Yan H; Qiu JX; Zhang CY; Qi JG; Zhang X; Xiao HJ; Yang YL; Chen YH; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):768-777. PubMed ID: 29045954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.
    Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC
    Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doppler echocardiography-right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension.
    Swanson KL; Utz JP; Krowka MJ
    Med Sci Monit; 2008 Apr; 14(4):CR177-82. PubMed ID: 18376344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan for patients with echocardiographic evidence of pulmonary hypertension due to long-standing rheumatic mitral stenosis.
    Vlachogeorgos GS; Daskalopoulos N; Blatsiotis P; Kourbeti IS; Mantas I; Stathopoulos GT
    Hellenic J Cardiol; 2015; 56(1):36-43. PubMed ID: 25701970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease.
    Ibrahim R; Granton JT; Mehta S
    Can Respir J; 2006; 13(8):415-20. PubMed ID: 17149459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.
    Alkukhun L; Wang XF; Ahmed MK; Baumgartner M; Budev MM; Dweik RA; Tonelli AR
    Respir Med; 2016 Aug; 117():65-72. PubMed ID: 27492515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
    Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
    Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
    Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosentan for idiopathic pulmonary fibrosis.
    King TE
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1171-9. PubMed ID: 18951296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
    Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
    Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.